Australian scientists create nanotech chemo delivery vehicle

05/10/2007 | Reuters

Australia-based EnGeneIC says it has developed nano-cells derived from bacteria that target cancer cells and deliver chemotherapy in significantly lower doses. The EnGeneIC delivery vehicles has had positive results in primate trials and the goal is to help patients more easily tolerate chemo treatment. A researcher said, "For the first time there is a real possibility that this technology could lead to the use of multi-drug combinations and eventual custom-made therapies in cancer patients."

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC